Puthenparampil, M., Cazzola, C., Zywicki, S., Federle, L., Stropparo, E., Anglani, M., . . . Gallo, P. (2018). NEDA-3 status including cortical lesions in the comparative evaluation of natalizumab versus fingolimod efficacy in multiple sclerosis. Ther Adv Neurol Disord.

Puthenparampil, Marco, Chiara Cazzola, Sofia Zywicki, Lisa Federle, Erica Stropparo, Mariagiulia Anglani, Francesca Rinaldi, Paola Perini, and Paolo Gallo. "NEDA-3 Status Including Cortical Lesions in the Comparative Evaluation of Natalizumab Versus Fingolimod Efficacy in Multiple Sclerosis." Ther Adv Neurol Disord 2018.

Puthenparampil, Marco, et al. "NEDA-3 Status Including Cortical Lesions in the Comparative Evaluation of Natalizumab Versus Fingolimod Efficacy in Multiple Sclerosis." Ther Adv Neurol Disord 2018.